Notice of registration.
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Start Supplemental Information
The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.
|Chattem Chemicals, Inc||81 FR 62177||September 8, 2016.|
|Anderson Brecon, Inc||81 FR 71766||October 18, 2016.|
|Hospira||82 FR 11241||February 21, 2017.|
|Myoderm||82 FR 13134||March 9, 2017.|
|Meridian Medical Technologies||82 FR 13135||March 9, 2017.|
|Start Printed Page 25336|
|Meda Pharmaceuticals, Inc||82 FR 13137||March 9, 2017.|
|Wildlife Laboratories, Inc||82 FR 14914||March 23, 2017.|
|Xcelience||82 FR 16420||April 4, 2017.|
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.
End Supplemental Information
Dated: May 23, 2017.
Louis J. Milione,
[FR Doc. 2017-11388 Filed 5-31-17; 8:45 am]
BILLING CODE 4410-09-P